
|Articles|January 25, 2008
Bausch & Lomb to buy eyeonics
Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.
Advertisement
Bausch & Lomb has entered into an agreement to purchase eyeonics, the maker of the Crystalens accommodating IOL.
Upon completion of the deal, Bausch & Lomb will absorb eyeonics' operations as part of its surgical business. Eyeonics generated approximately $34 million in revenue in 2007, a 100% increase over the prior year.
The acquisition is expected to complete within the first quarter of 2008.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Port Delivery System Therapies in Retinal Vascular Diseases
2
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
3
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
4
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
5






















